www.fdanews.com/articles/85905-pharmaxis-obtains-license-to-manufacture-inhalation-powders-for-human-use
PHARMAXIS OBTAINS LICENSE TO MANUFACTURE INHALATION POWDERS FOR HUMAN USE
April 7, 2006
Friday morning, Pharmaxis Ltd., a specialist pharmaceutical company, revealed that it obtained a Good Manufacturing Practices License from the Therapeutic Goods Administration or TGA to manufacture inhalation powders for human use that excludes microbiological testing.
Trading
Markets